AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Oct 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-09-29

Reporting Person: Quimi Daphne (VP Finance and Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-29	Common stock	P	10738	$6.0966	Acquired	60738	Direct
2014-09-29	Common stock	S	10738	$6.0966	Disposed	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-29	Stock Options (right to buy)	$2.52	M	4738	Disposed	2023-06-18	Common Stock (4738)	Direct
2014-09-29	Stock Options (right to buy)	$2.81	M	6000	Disposed	2020-06-15	Common Stock (6000)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2014.

F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $5.91 to $6.25. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $5.91 to $6.25. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.